HTGMQ vs. GNCA, KLDO, UTRS, VIVE, ONCSQ, AHPI, VRAYQ, NOVNQ, IDXG, and PRPO
Should you be buying HTG Molecular Diagnostics stock or one of its competitors? The main competitors of HTG Molecular Diagnostics include Genocea Biosciences (GNCA), Kaleido Biosciences (KLDO), Minerva Surgical (UTRS), Viveve Medical (VIVE), OncoSec Medical (ONCSQ), Allied Healthcare Products (AHPI), ViewRay (VRAYQ), NVN Liquidation (NOVNQ), Interpace Biosciences (IDXG), and Precipio (PRPO). These companies are all part of the "medical" sector.
HTG Molecular Diagnostics (NASDAQ:HTGMQ) and Genocea Biosciences (NASDAQ:GNCA) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, profitability, institutional ownership, dividends, analyst recommendations, valuation and community ranking.
HTG Molecular Diagnostics has higher revenue and earnings than Genocea Biosciences.
Genocea Biosciences received 388 more outperform votes than HTG Molecular Diagnostics when rated by MarketBeat users.
HTG Molecular Diagnostics' return on equity of 0.00% beat Genocea Biosciences' return on equity.
HTG Molecular Diagnostics has a beta of 2.73, indicating that its share price is 173% more volatile than the S&P 500. Comparatively, Genocea Biosciences has a beta of 1.61, indicating that its share price is 61% more volatile than the S&P 500.
0.6% of Genocea Biosciences shares are held by institutional investors. 2.6% of HTG Molecular Diagnostics shares are held by insiders. Comparatively, 1.6% of Genocea Biosciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
In the previous week, HTG Molecular Diagnostics' average media sentiment score of 0.00 equaled Genocea Biosciences'average media sentiment score.
Summary
HTG Molecular Diagnostics beats Genocea Biosciences on 6 of the 8 factors compared between the two stocks.
Get HTG Molecular Diagnostics News Delivered to You Automatically
Sign up to receive the latest news and ratings for HTGMQ and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HTGMQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
HTGMQ vs. The Competition
HTG Molecular Diagnostics Competitors List
Related Companies and Tools
